RecruitingPhase 2NCT06887192
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Sponsor: MapLight Therapeutics
Augusta, GA · Snellville, GA · +35 more sites
5 recruiting schizophrenia studies with a site in Snellville, GA.
Sponsor: MapLight Therapeutics
Augusta, GA · Snellville, GA · +35 more sites
Sponsor: LB Pharmaceuticals Inc.
Atlanta, GA · Snellville, GA · +21 more sites
Sponsor: LB Pharmaceuticals Inc.
Snellville, GA · +12 more sites
Sponsor: Neurocrine Biosciences
Atlanta, GA · Decatur, GA · Snellville, GA · +18 more sites
Sponsor: Alto Neuroscience
Snellville, GA · +13 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.